John E. Morley, MB, BCh Director, Division of Geriatric Medicine, St. Louis University Health Sciences Center, Missouri Geriatric Research, Education and Clinical Center, St. Louis Veterans Administration Medical Center
Address: John E. Morley, MB, BCh, St. Louis University Health Sciences Center, 1402 South Grand Boulevard, Room M238, St. Louis, MO 63104
The author has indicated that he has relationships which, in the context of his presentation, could be perceived as potential conflict of interest. He has received grants or research support from Merck, Nestec, Bayer, and B. Braun McGaw, and has served on the speaker's bureau for LXN, Organon, GeriMed of America, UniMed, Essentia, Alza, Pharmacia & Upjohn, Glaxo Wellcome, B. Braun McGaw, Bristol-Myers Squibb, Hoechst Marion Roussel, Merck, Novartis, Parke-Davis, Smithkline Beecham, and Pfizer.
ABSTRACT
Testosterone therapy can improve quality of life in aging men because aging is accompanied by declining testosterone levels that may contribute to decreases in muscle mass, bone density, libido, stamina, and cognition. Hypogonadal men can be identified by a test for bioavailable testosterone or by a free testosterone assay that uses dialysis or ultracentrifugation methods.
